Skip to content
34
Societies
SSMO,
SSH
Categories
Joint Session

Oral presentations Experimental hematology / oncology

- , Shanghai 1-2

Schedule Slot

Oral presentations Experimental hematology / oncology

34
Societies
SSMO,
SSH
Categories
Joint Session

Oral presentations Experimental hematology / oncology

- , Shanghai 1-2
Chair:
Steffen Böttcher (University Hospital Zurich)
Benjamin Kasenda (Universitätsspital Basel)

  1. Clinical transcriptomics reveal therapeutically highly relevant alterations in adult Ph- B-ALL

    Presentation time:
    9 min
    Discussion time:
    3 min

    Speaker: Rieger (UniversitätsSpital Zürich)

  2. Dual inhibition of JAK2 and Gas6/TAM signaling mitigates disease progression and vascular complications in polycythemia vera

    Presentation time:
    9 min
    Discussion time:
    3 min

    Speaker: Knopp (Inselspital)

  3. JAK2 signalling to HNRNPA1 represses retrotransposon activity in haematopoietic stem cells and protects the genome.

    Presentation time:
    9 min
    Discussion time:
    3 min

    Speaker: Deuel (UniversitätsSpital Zürich)

  4. Divergent Effects of Tet2- and Dnmt3a-mutant Clonal Hematopoiesis on Breast Cancer Progression Upon Aging

    Presentation time:
    9 min
    Discussion time:
    3 min

    Speaker: Gönüllü (University Hospital Zurich)

  5. Drivers of Therapy-Related Clonal Hematopoiesis and Its Progression to Myeloid Neoplasms

    Presentation time:
    9 min
    Discussion time:
    3 min

    Speaker: Koch (University of Zurich and University Hospital Zurich)

  6. A Human CRISPR-Engineered MLLr Leukemia Model Enables Functional Analysis Across MLL Fusion Variants

    Presentation time:
    9 min
    Discussion time:
    3 min

    Speaker: Radszuweit (University Hospital Zurich)

  7. Enhancing bispecific T-cell engagers and activators by CD33 selective co-stimulation

    Presentation time:
    9 min
    Discussion time:
    3 min

    Speaker: Hofstetter (University Hospital Zurich)